Evidence map›Paper›PMID 34033074›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.

Jane Kovalevich, Maryline Santerre, Dianne Langford

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Targeting ATScientific reports · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Synthesis and Evaluation ofLife (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jane KovalevichDepartment of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Maryline SanterreMolecular Studies of Neurodegenerative Diseases Lab, FELS Institute, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Dianne LangfordDepartment of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA. tdl@temple.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of primary mammalian neurons derived from embryonic central nervous system tissue is limited by the fact that once terminally differentiated into mature neurons, the cells can no longer be propagated. Transformed neuronal-like cell lines can be used in vitro to overcome this limitation. However, several caveats exist when utilizing cells derived from malignant tumors. In this context, the popular SH-SY5Y neuroblastoma cell line and its use in in vitro systems is described. Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC

Indexed as

NeurobiologyNeurogenesisBiomarkersCell AdhesionCell Culture TechniquesCell LineageCell Line, TumorCell ProliferationCryopreservationHumansNeuroblastomaNeuronsPhenotypeTretinoinBiomarkersTretinoinCNSDifferentiationNeurobiologyNeuroblastomaNeuron

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.